Sanofi could try to differentiate Zantac 360 among histamine-2 blockers in the OTC heartburn remedy category by qualifying and modifying its “#1 doctor recommended” claim that an industry self-regulation group’s appeals panel says it didn’t support.
The French firm asked BBB National Programs Inc.’s National Advertising Review Board to consider using a claim of “#1 doctor...